Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will present at the 44th Annual J.P.
A growing number of companies offer the enticing promise of optimizing one’s health by tapping into powerful technology they say can map out what diseases a person is susceptible to and possibly catch ...
Veteran oncology and value-based care leader joins to guide Medzown’s next phase of growthBOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medzown (“Medzown” or the “Company”), a precision medicine ...
Policy, precision medicine, and new ways of delivering therapeutics were popular topics in 2025 among readers of Evidence-Based Oncology ™ (EBO), the multistakeholder cancer care publication of The ...
Robotic surgery is reshaping modern medicine. A combination of robotics and advanced imaging technologies allows surgeons to ...
Precision medicine is one of the most promising and novel approaches to controlling excessive healthcare costs and providing a meaningful benefit through improved disease diagnosis, treatment and ...
Precision medicine tailors healthcare to an individual’s genes, environment, and lifestyle, moving beyond a one-size-fits-all approach. Health insurance coverage significantly impacts access to ...
Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a ...
Precision medicine is evolving from a concept to clinical viability, albeit in limited settings. In his 2015 State of the Union address, President Barack Obama called for a federally funded, ...
Written by Abigail Sawyer, Jenny Straiton and Tristan Free. Figure 1: The top ten highest-grossing drugs in the USA illustrating how many people’s conditions improve from taking them [1]. Precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results